Founded Year
2003Stage
Series B - III | AliveTotal Raised
$6.38MLast Raised
$150K | 8 yrs agoAbout Plurogen Therapeutics
PluroGen Therapeutics provides clinically advanced and advantaged burn, wound and skin care products. The company works closely with doctors, nurses, patients and healthcare institutions to provide the best products for burn, wound and skin care to help people have a better quality of life. The Company's primary platform is its core PluroGel surfactant technology which provides products with paradigm-shifting, superior and differentiated Core, Bio-Physical, and Performance Functions resulting in unique and advantaged Multi-Function products.
Plurogen Therapeutics Headquarter Location
2495 General Armistead Ave
Norristown, Pennsylvania, 19403,
United States
610-539-3670
Latest Plurogen Therapeutics News
Dec 6, 2016
PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 18:07 EST 6 Dec 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by PluroGen Therapeutics, Inc. since January 2007. Key Findings Provides intelligence on PluroGen Therapeutics, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by PluroGen Therapeutics, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for PluroGen Therapeutics, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about PluroGen Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
Expert Collections containing Plurogen Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Plurogen Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,238 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Plurogen Therapeutics Patents
Plurogen Therapeutics has filed 7 patents.
The 3 most popular patent topics include:
- Antibiotics
- Antimicrobial peptides
- Antimicrobials
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/20/2016 | 10/29/2019 | Bacteriology, Antibiotics, Inflammations, Microbiology, Immune system | Grant | |
Application Date | 1/20/2016 | ||||
|---|---|---|---|---|---|
Grant Date | 10/29/2019 | ||||
Title | |||||
Related Topics | Bacteriology, Antibiotics, Inflammations, Microbiology, Immune system | ||||
Status | Grant |